Michael Egholm - 04 Apr 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
President & CEO, Director
Signature
/s/ Michael Egholm by Nicholas Khadder, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
04 Apr 2022
Net transactions value
$0
Form type
4
Filing time
06 Apr 2022, 18:35:59 UTC
Previous filing
07 Oct 2021
Next filing
21 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +786,049 $0.000000 786,049 04 Apr 2022 Common Stock 786,049 Direct F1, F2
transaction LAB Stock Option (Right to Buy) Award $0 +4,529,773 $0.000000 4,529,773 04 Apr 2022 Common Stock 4,529,773 $3.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F2 Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.
F3 The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.